Sarepta Therapeutics Announces Publication of Positive Long-Term Safety and Efficacy Data for Eteplirsen in the Annals of Neurology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. CL
3. SNDK
4. TAP
5. DELL
6. ROIV
7. ANET
8. NKE
9. PANW
10. SPG

Go back to Sarepta Therapeutics Announces Publication of Positive Long-Term Safety and Efficacy Data for Eteplirsen in the Annals of Neurology
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 22.50 -0.49 (2.13%)
Previous Close $22.99    52 Week High $63.73 
Open $22.58    52 Week Low $8.00 
Day High $22.65    P/E N/A 
Day Low $21.98    EPS $-5.69 
Volume 2,955,534